Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 40 of 40 publications.

Seeger JD, Jonsson Funk M, Bradley Layton J, Lloyd P. Considerations of misclassification and confounding on COVID-19 vaccines effectiveness studies - a Vaccine SIG endorsed symposium. Presentation to be given at the 2022 ICPE Conference; August 26, 2022. Copenhagen, Denmark.

Butler AM, Layton JB, Krueger WS, Kshirsager AV, McGrath LJ. Assessing residual bias in estimating influenza vaccine effectiveness: comparison of high-dose versus standard-dose vaccines. Med Care. 2019 Jan;57(1):73-8. doi: 10.1097/MLR.0000000000001018

McGrath LJ, Layton JB, Krueger WS, Kshirsagar AV, Butler AM. High-dose influenza vaccine use among patients receiving hemodialysis in the United States, 2010-2013. Vaccine. 2018 Oct 1;36(41):6087-94. doi: 10.1016/j.vaccine.2018.08.079

Layton JB, Butler AM, Panozzo CA, Brookhart MA. Rotavirus vaccination and short-term risk of adverse events in US infants. Paediatr Perinat Epidemiol. 2018 Sep;32(5):448-57. doi: 10.1111/ppe.12496

Butler AM, Layton JB, Krueger WS, Kshirsagar AV, McGrath LJ. Estimating influenza vaccine effectiveness: using an active comparator reduces bias due to confounding by frailty. Poster presented at the 34th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 25, 2018. Prague, Czech Republic. [abstract] Pharmacoepidemiol Drug Saf. 2018 Aug; 27(S2):229. doi: 10.1002/pds.4629

Baker M, Jankosky C, Yih K, Gruber S, Li L, Cocoros N, Lipowicz H, Coronel-Moreno C, Feibelmann S, Lin N, McMahill-Walraven C, Menschik D, Selvan M, Selvam N, Tilney RC, Zichittella L, Lee G, Kawai AT. The risk of febrile seizures following influenza and 13-valent pneumococcal conjugate vaccines. Poster presented at the 2017 Infectious Disease Week Conference; October 6, 2017. San Diego, CA. [abstract] Open Forum Infect Dis. 2017 Oct; 4(Suppl 1):S464-5. doi: 10.1093/ofid/ofx163.1187

Kawai AT, Anderson S, Andrade SE, Zichittella L, Stockdale C. Developing capabilities to monitor the safety of vaccine use during pregnancy in Sentinel's Prism Program. Presented at the 4th International Neonatal & Maternal Immunization Symposium; September 2017. Brussels, Belgium.

Boggess K, Butler A, Layton JB, Li D, Hudgens M, McGrath L, Weber D, Becker-Dreps S. Tdap vaccination rates among 1.2 million privately insured pregnant women, 2010-2014. Poster presented at the 37th Annual Meeting of the Society for Maternal Fetal Medicine: The Pregnancy Meeting; January 2017. Las Vegas, NV. [abstract] Am J Obstet Gynecol. 2017 Jan; 216(Suppl 1):S204. doi: 10.1016/j.ajog.2016.11.594

Li R, Stewart B, McNeil MM, Duffy J, Nelson J, Kawai AT, Baxter R, Belongia EA, Weintraub E. Post licensure surveillance of influenza vaccines in the Vaccine Safety Datalink in the 2013-2014 and 2014-2015 seasons. Pharmacoepidemiol Drug Saf. 2016 Aug;25(8):928-34. doi: 10.1002/pds.3996

Yih WK, Kulldorff M, Sandhu SK, Zichittella L, Maro JC, Cole DV, Jin R, Kawai AT, Baker MA, Liu C, McMahill-Walraven CN, Selvan MS, Platt R, Nguyen MD, Lee GM. Prospective influenza vaccine safety surveillance using fresh data in the Sentinel System. Pharmacoepidemiol Drug Saf. 2016 May;25(5):481-92. doi: 10.1002/pds.3908

Kawai AT, Martin D, Kulldorff M, Li L, Cole DV, McMahill-Walraven CN, Selvam N, Selvan MS, Lee GM. Febrile seizures after 2010-2011 trivalent inactivated influenza vaccine. Pediatrics. 2015 Oct;136(4):e848-855. doi: 10.1542/peds.2015-0635

Zhang HT, McGrath LJ, Wyss R, Ellis AR, Sturmer T. Improving control for confounding by frailty when estimating influenza vaccine effectiveness in older adults. Poster presented at the 31st International Conference on Pharmacoepidemiology and Therapeutic Risk Management; August 2015. Boston, MA.

McGrath LJ, Brookhart MA. Use of the high-dose influenza vaccine among commercially insured patients in the United States, 2010-2012. Poster presented at the 31st International Conference on Pharmacoepidemiology and Therapeutic Risk Management; August 2015. Boston, MA.

McGrath LJ, Ellis AR, Brookhart MA. Controlling time-dependent confounding by health status and frailty: restriction versus statistical adjustment. Am J Epidemiol. 2015 Jul 1;182(1):17-25. doi: 10.1093/aje/kwu485

Baker MA, Lieu TA, Li L, Hua W, Qiang Y, Kawai AT, Fireman BH, Martin DB, Nguyen MD. A vaccine study design selection framework for the postlicensure rapid immunization safety monitoring program. Am J Epidemiol. 2015 Apr 15;181(8):608-18. doi: 10.1093/aje/kwu322

Jackson ML, Rothman KJ. Effects of imperfect test sensitivity and specificity on observational studies of influenza vaccine effectiveness. Vaccine. 2015 Mar 10;33(11):1313-6. doi: 10.1016/j.vaccine.2015.01.069

McGrath LJ, Brookhart MA. On-label and off-label use of high-dose influenza vaccine in the United States, 2010-2012. Hum Vaccin Immunother. 2015 Mar 4;11(3):537-44. doi: 10.1080/21645515.2015.1011026

Kawai AT, Martin D, McMahill-Walraven C, Selvam N, Selvan M, Lee G, Mini-Sentinel PRISM Team. Validation of febrile seizures identified in the Mini-Sentinel Post-Licensure Rapid Immunization Safety Monitoring (PRISM) system. Poster presented at the 2014 Infectious Diseases Society of America; October 10, 2014. Philadelphia, PA.

Kawai AT. Assessment of febrile seizures after trivalent influenza vaccines during the 2010-2011 influenza season in PRISM. Presented at the Brookings Institution Roundtable on Active Medical Product Surveillance; July 21, 2014.

Kawai AT. Febrile seizures after TIV: PRISM System, 2010-2011 influenza season. Presented at the 2014 Advisory Committee on Immunization Practices (ACIP); June 2014. Atlanta, GA.

Kawai AT, Li L, Kulldorff M, Vellozzi C, Weintraub E, Baxter R, Belongia EA, Daley MF, Jacobsen SJ, Naleway A, Nordin JD, Lee GM. Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barré syndrome, encephalitis, or anaphylaxis in the 2012-2013 season. Pharmacoepidemiol Drug Saf. 2014 May;23(5):548-53. doi: 10.1002/pds.3575

Rogawski E, McGrath L, Vielot N, Westreich D. Ischaemic heart disease, influenza and influenza vaccination: a prospective case control study - Letter to editor. Heart. 2014 Mar;100(6):517-8. doi: 10.1136/heartjnl-2013-305406.

McGrath LJ, Cole SR, Kshirsagar AV, Weber DJ, Stürmer T, Brookhart MA. Hospitalization and skilled nursing care are predictors of influenza vaccination among patients on hemodialysis: evidence of confounding by frailty. Med Care. 2013 Dec;51(12):1106-13. doi: 10.1097/MLR.0b013e3182a50297

Villa M, Black S, Groth N, Rothman KJ, Apolone G, Weiss NS, Aquino I, Boldori L, Caramaschi F, Gattinoni A, Malchiodi G, Crucitti A, Della Cioppa G, Scarpini E, Mavilio D, Mannino S. Safety of mf59-adjuvanted influenza vaccination in the elderly: results of a comparative study of mf59-adjuvanted vaccine versus nonadjuvanted influenza vaccine in northern Italy. Am J Epidemiol. 2013 Oct;178(7):1139-45.

McGrath LJ, Kshirsagar AV. Influenza and pneumococcal vaccination in dialysis patients: merely a shot in the arm? Am J Kidney Dis. 2012 Dec;60(6):890-2. doi: 10.1053/j.ajkd.2012.09.001

Tse (Kawai) A, Tseng HF, Greene SK, Vellozzi C, Weintraub E, McCarthy N. Risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011. Poster presented at the 28th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2012. Barcelona, Spain. [abstract] Pharmacoepidemiol Drug Saf. 2012 Aug; 21(Suppl 3):365-6.

Brookhart MA, McGrath LJ. The influenza vaccine in elderly persons: a shot in the dark? Comment on "Estimating influenza vaccine effectiveness in community-dwelling elderly patients using the instrumental variable analysis method.". Arch Intern Med. 2012 Mar 26;172(6):492-3. doi: 10.1001/archinternmed.2011.2041

McGrath LJ, Kshirsagar A, Cole SR, Wang L, Weber DL, Stürmer T. Evaluating influenza vaccine effectiveness among hemodialysis patients using a natural experiment. Arch Intern Med. 2012;172(7):548-54.

Tennis P, Toback SL, Andrews E, McQuay L, Ambrose CS. A postmarketing evaluation of the frequency of use and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years. Vaccine. 2011 Jul 1;29(31):4947-52. doi: 10.1016/j.vaccine.2011.04.113

Tennis PS, Andrews EB, Tobak S, Ambrose C, McQuay LJ, Rousculp M. Claims algorithms to quantify use of live attenuated influenza vaccine among non-recommended children. Poster presented at the 26th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2010. Brighton, UK. [abstract] Pharmacoepidemiol Drug Saf. 2010 Aug; 19(Suppl 1):S239.

Gray GC, Baker (Krueger) WS. The importance of including swine and poultry workers in influenza vaccination programs. Clin Pharmacol Ther. 2007 Dec;82(6):638-41.

Rothman KJ, Arellano FM, Young-Xu Y, Simonsen L. Reply to "is there a safe age for vaccinating infants with tetravalent rhesus-human reassortant rotavirus vaccine?". J Infect Dis. 2006 Dec;194(12):1793-4.

Rothman KJ, Young-Xu Y, Arellano F. Age dependence of the relation between reassortant rotavirus vaccine (RotaShield) and intussusception. J Infect Dis. 2006 Jan 1;193(6):898.

Midkiff KD. General interviewing techniques for the HPV vaccine trial computer assisted personal interview (CAPI). Poster presented at the Guanacaste Epidemiology Project; May 2004.

Davies EG, Riddington C, Lottenberg R, Dower N. Pneumococcal vaccines for sickle cell disease. Cochrane Database Syst Rev. 2004 Jan 1;(1).

Liu Z, Eaton SC, McQuay LJ, Mines D, Irish WD, Wang L. Protective value of influenza vaccination for other household members of vaccinated children. Poster presented at the 2003 41st Annual Meeting of the Infectious Disease Society of America; October 2003. San Diego, CA.

Black C, Kaye JA, Jick H. MMR vaccine and idiopathic thrombocytopaenic purpura. Br J Clin Pharmacol. 2003 Jan;55(1):107-11.

Black C, Kaye JA, Jick H. Measles, mumps and rubella vaccine and risk of idiopathic thrombocytopaenic purpura. Poster presented at the 18th International Conference on Pharmacoepidemiology; August 17, 2002. Edinburgh, Scotland. [abstract] Pharmacoepidemiol Drug Saf. 2002 Aug; 11(S8).

Kaye JA, del Mar Melero-Montes M, Jick H. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ. 2001 Feb 24;322(7284):460-3.

Andrews EB, Avorn J, Bortnichak EA, Chen R, Dai WS, Dieck GS, Edlavitch S, Freiman J, Mitchell AA, Nelson RC, Neutel CI, Stergachis A, Strom BL, Walker AM. Guidelines for Good Epidemiology Practices for drug, device, and vaccine research in the United States. Pharmacoepidemiol Drug Saf. 1996 Sep 1;5(5):333-8.